Evaluation of Live Attenuated Influenza Vaccines in Children 6-18 Months of Age: Safety, Immunogenicity, and Efficacy
Live attenuated, cold-adapted (ca) monovalent and bivalent influenza A vaccines were evaluated in seronegative infants (ages 6–18 months) in a double-blind placebo-controlled trial to assess safety and immunogenicity. A total of 182 seronegative subjects received a single intranasal dose (106.2 TCID...
Uloženo v:
Hlavní autoři: | William C. Gruber, Robert B. Belshe, James C. King, John J. Treanor, Pedro A. Piedra, Peter F. Wright, George Reed, Elizabeth M. Anderson, Frances K. Newman |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
1996
|
On-line přístup: | https://doi.org/10.1093/infdis/173.6.1313 https://academic.oup.com/jid/article-pdf/173/6/1313/3284622/173-6-1313.pdf |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children
Autor: Stan L. Block, a další
Vydáno: (2012) -
Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
Autor: Belshe, R B, a další
Vydáno: (2001) -
Prevention of otitis media in children with live attenuated influenza vaccine given intranasally
Autor: Robert B. Belshe, a další
Vydáno: (2000) -
Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus Vaccine
Autor: Robert B. Belshe, a další
Vydáno: (2000) -
Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age
Autor: Belshe, Robert B., a další
Vydáno: (2010)